Related Experiment Video
Updated: May 16, 2025

Osteoclast Derivation from Mouse Bone Marrow
Published on: November 6, 2014
The role of osteopontin in chronic kidney disease-mineral bone disorder
Eduardo J Duque1, Cecilia Giachelli2, Rosa M A Moysés3
1Division of Nephrology and Hypertension, Center for Translational Metabolism and Health, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
Purpose Of Review:
Chronic kidney disease-mineral bone disorder (CKD-MBD) is associated with several adverse outcomes, including bone fragility and sarcopenia. Identification of new agents mitigating systemic damage related to uremia is critical and needed to unveil pathways implicated in CKD-MBD.
Recent Findings:
Osteopontin (OPN) is involved in different physiological and pathological processes and works as a bridge connecting several systems. It may serve as a biomarker for many diseases, including human cancers, neurodegenerative disorders and autoimmune diseases. OPN has been implicated in disturbances of bone mineralization and remodeling, and has an interplay with parathyroid hormone and FGF23 in experimental models. In patients with CKD and severe hyperparathyroidism, OPN expression in muscle tissue has been linked to worse functionality and local inflammation, which is partially reverted after parathyroidectomy.
Summary:
Future studies could confirm the role of OPN as a biomarker in nephrology. Greater understanding of its role in CKD-MBD will help us define a better therapeutic strategy in patients with CKD.
Insights
Osteopontin (OPN) may serve as a biomarker for chronic kidney disease-mineral bone disorder (CKD-MBD). Understanding OPN
Area of Science:
- Nephrology
- Endocrinology
- Bone Biology
Background:
- Chronic kidney disease-mineral bone disorder (CKD-MBD) is linked to bone fragility and sarcopenia.
- Uremia-related systemic damage requires new therapeutic agents and pathway identification.
Purpose of the Study:
- To explore the role of Osteopontin (OPN) in CKD-MBD.
- To investigate OPN as a potential biomarker and therapeutic target in CKD.
Main Methods:
- Review of existing literature on Osteopontin (OPN) in physiological and pathological processes.
- Analysis of OPN's involvement in bone mineralization, remodeling, and its interplay with parathyroid hormone and FGF23.
- Examination of OPN expression in muscle tissue of CKD patients with hyperparathyroidism.
Main Results:
- Osteopontin (OPN) is implicated in bone mineralization and remodeling disturbances.
- OPN expression in muscle tissue correlates with reduced functionality and inflammation in CKD patients, which improves after parathyroidectomy.
- OPN acts as a bridge between multiple physiological systems and may indicate various diseases.
Conclusions:
- Osteopontin (OPN) shows potential as a biomarker in nephrology.
- Further research into OPN's role in CKD-MBD can inform better therapeutic strategies for CKD patients.
More Related Videos
Related Concept Videos
Osteoclasts in Bone Remodeling
Bone Remodeling
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Essential Minerals for Bone Health
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Skeleton and Calcium Homeostasis

